Skip to main content

BeiGene wins Scrip Award

| News

BeiGene wins Scrip Award

06.12.2019

The pharmaceutical company BeiGene has won a Scrip Award that recognizes contributions across the pharma sector to improving healthcare. BeiGene’s European headquarters is located in Basel.

The winners of the Scrip Awards 2019 (img: franzel.schneider@informa.com)

The 15th edition of the Scrip Awards this year honored companies in pharma, biotech and associated sectors that are making important contributions to improving healthcare. The Chinese company BeiGene won the award in the category Masters Speciality Pharma’s Best Company in an Emerging Market. The globally active company from Beijing opened its European headquarters in Basel in 2018, with the settlement facilitated by BaselArea.swiss.

BeiGene specializes in the development of cancer therapies. Seeking to secure a leading role worldwide in the discovery, development and commercialization of drugs for targeted cancer treatment and the field of immuno-oncology, the company looks to distinguish itself with innovative approaches. It has now succeeded in this at the Scrip Awards, where it beat five other companies nominated in the category Masters Speciality Pharma’s Best Company in an Emerging Market.

Awards were given in 17 categories. Novartis and AveXis won IQVIA’s Clinical Advance of the Year Award, which recognizes a clinical Phase III study on Zoglensma – a gene therapy for the degenerative nervous system disease amyotrophic lateral sclerosis (ALS). The American company AveXis was acquired last year by the Basel pharmaceutical company Novartis.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Forty51 Ventures invests to found Mysthera Therapeutics

Mysthera Therapeutics AG has been founded in Basel. Forty51 Ventures, a venture capital firm also based in Basel, has provided...
Read More

Spexis receives capital commitment of 2.5 million US dollars

Investors have made an additional capital commitment to Spexis AG, based in the Basel Area. With an extra 2.5 million...
Read More

Worg secures financing of 130 million Swiss francs

The Chinese biopharmaceutical firm Worg Pharma, whose European headquarters are located in the Basel Area, has secured gross proceeds equivalent...
Read More

Tenpoint aims to make vision loss reversible

The startup Tenpoint Therapeutics has started operations with a funding round of 70 million US dollars. It works to make...
Read More

Roche and ETH training the next generation of researchers

Roche, the Basel-based life sciences firm, and the Swiss Federal Institute of Technology in Zurich (ETH) are joining forces to...
Read More

Clear Solutions Labs seeks to benefit from the Basel Area

The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science...
Read More

QuantumBasel offers access to the world’s most powerful quantum computers

QuantumBasel has consolidated its status as a neutral quantum hub with access to the world’s best quantum computers through a...
Read More

How digital transformation is driving pharmaceutical innovation in Basel

How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to improve drug research and development?...
Read More

Medical informatics is shaping Switzerland’s digital future

Switzerland is at the forefront of embracing medical informatics, and innovative biotech hubs – such as the Basel Area –...
Read More

Ground-breaking oncology being developed in the Basel Area

The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true...
Read More

Genedata expanding its user network

The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...
Read More

How Moderna is growing in Switzerland

The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read More

Sandoz decides on Basel for headquarters

Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read More

VectivBio sold for approximately 1 billion dollars

The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read More

University of Basel and RocketVax present new Covid vaccine

Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read More

Rami Swiss and Elbit Systems now manufacturing in Jura

The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read More
1 2 3 12

Do you have a question? We'd like to hear from you.